A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.
about
Treating Negative Symptoms in Schizophrenia: an UpdateAttachment, Neurobiology, and Mentalizing along the Psychosis ContinuumContribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disordersPotential of Oxytocin in the Treatment of SchizophreniaUnderstanding the Oxytocin System and Its Relevance to Psychiatry.Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications.Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β-Arrestin-Independent InternalisationOverview of Human Oxytocin Research.Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.Oxytocin and behavior: Lessons from knockout mice.Personalized medicine in psychiatry.Lifespan oxytocin signaling: Maturation, flexibility, and stability in newborn, adolescent, and aged brain.Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.Oxytocin and Human Evolution.Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin.Oxytocin and social functioning.Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders.Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know.A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.Rodent models of genetic and chromosomal variations in psychiatric disorders.Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia.Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment - need for more short- and long-term studies
P2860
Q26744805-9054D1AD-1B11-45E5-A89A-B55793C4D159Q28069770-BAB8F9F4-F24A-47BD-86E9-B04BA3282F4DQ30490336-5BA2C54F-243A-408D-9447-CE26D56DF06AQ33761384-12C58851-0814-4384-B295-8B4B0AF1885CQ36479014-6C6BC410-754B-4A90-A4E5-831602ECBE4DQ36950108-86F158CC-586C-4181-9A33-B0A37EF22493Q37252520-B5A8C2E1-3B19-4019-9FE8-ACA0612BE660Q38634070-63F6AC3F-37C5-44CE-B8D5-AA6F7A8A789AQ38674187-39725E30-52B6-41E1-AA27-78216BF47B0DQ38683538-854CC9AC-E48F-4E99-A9BA-9B06EF5EC20DQ38924683-36A8AC4B-C584-4A9D-B9FA-DC021A01A204Q38937776-B586C3D7-C9C8-407D-AC53-3DF225F7D3E0Q38948468-EF8D00BB-67C1-46F8-9163-F1611F3003D9Q39084549-6BC4142F-E49E-41B9-86D6-A209DE9C7F38Q39311315-D80A0997-9E22-43FA-8B53-111EB10A677AQ40160232-722EA03B-39EC-4FA0-BB7E-930371DF96D9Q41535736-A086BB6A-4822-45C3-8A24-01A6812C748FQ41653828-2FE5FB52-64A1-4E03-A860-576520807873Q45972914-128C5DE3-2266-4413-BD28-8AF016478079Q47739826-F5F6B0EC-3C27-43DF-8F2D-125DC5C2AF3CQ48019733-D09D4682-E78D-4AF6-8229-A818C6448136Q48257043-E8773699-048F-444A-A636-1946486DFA27Q48377556-19E9EF28-EE12-4B1B-9DE1-781B32FC8CB6Q57483188-F5D2FFEB-5B26-43FB-A297-BDB031381358
P2860
A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Review of Oxytocin's Effects ...... tive Domains of Schizophrenia.
@en
type
label
A Review of Oxytocin's Effects ...... tive Domains of Schizophrenia.
@en
prefLabel
A Review of Oxytocin's Effects ...... tive Domains of Schizophrenia.
@en
P2093
P2860
P1476
A Review of Oxytocin's Effects ...... tive Domains of Schizophrenia.
@en
P2093
David Feifel
Kai MacDonald
Paul D Shilling
P2860
P304
P356
10.1016/J.BIOPSYCH.2015.07.025
P407
P577
2015-08-13T00:00:00Z